Dr. Posadas named director of Cedars-Sinai GU oncology program
Edwin Posadas, MD, has joined Cedars-Sinai Medical Center, Los Angeles, as the clinical director of the genitourinary medical oncology program in the Samuel Oschin Comprehensive Cancer Institute.
Edwin Posadas, MD, has joined Cedars-Sinai Medical Center, Los Angeles, as the clinical director of the genitourinary medical oncology program in the Samuel Oschin Comprehensive Cancer Institute.
In his research, Dr. Posadas has focused on mechanisms through which cancer cells in localized tumors spread. In upcoming studies at Cedars-Sinai, he will work to define the protein FYN’s function in prostate cancer cells, with the goal of applying his basic science findings to developing new therapies to benefit men with advanced prostate cancer.
"Dr. Posadas is an innovative researcher focused on finding effective ways to treat cancer and stop it from spreading," said Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute and Phase One Foundation Chair. "His understanding of the molecular mechanisms of cancer growth may well lead to targeted therapies that stop cancer cells from gaining footholds in other organs, essentially keeping the disease contained and manageable."
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.
